Lewis Lanier

Professor and Chair

University of California, San Francisco

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lewis Lanier is a Professor and Chair at the University of California San Francisco, USA. His research focuses on natural killer (NK) cell biology, particularly in the context of cardiovascular diseases, cancer immunology, and the interplay between NK cells and viral infections. Recent publications include studies on NK cell receptor signaling, immune responses, and the effects of human cytomegalovirus on NK cell function.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Matthew Feinstein

Assistant Professor of Medicine (Cardiology), Pathology, and Preventive Medicine

Northwestern University

UNITED STATES

View details

Daniel Chen

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

John Greenland

Associate Professor

UCSF Medical Center

UNITED STATES

View details

Joseph C. Sun

UNITED STATES

View details

KENICHI ISHIYAMA

Assistant professor

Kyoto University

JAPAN

View details

Ryosuke Saigusa

Tohoku University graduate school of medicine

JAPAN

View details

James Heath

Professor

California Institute of Technology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lewis Lanier

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

CITE-Seq Analysis Reveals a Differential Natural Killer Cell SPON2 Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and Diabetes

Five decades of natural killer cell discovery

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

ITAM‐based receptors in natural killer cells

Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T Cells

Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression

Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion

The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling

Influence of Self–MHC Class I Recognition on the Dynamics of NK Cell Responses to Cytomegalovirus Infection

A functional mammalian display screen identifies rare antibodies that stimulate NK cell–mediated cytotoxicity

Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells

Immigration in science

Tetramer Immunization and Selection Followed by CELLISA Screening to Generate Monoclonal Antibodies against the Mouse Cytomegalovirus m12 Immunoevasin

Collaborators (7)

Matthew Feinstein

Daniel Chen

John Greenland

Joseph C. Sun

KENICHI ISHIYAMA

Ryosuke Saigusa

James Heath

Make your next move.